David H. Blankenhorn

Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts

David H. Blankenhorn · JAMA · 1987 · 1.6K citations

Medicine, Pharmacology, Pharmacotherapy +17

Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)

David H. Blankenhorn · Annals of Internal Medicine · 1993 · 643 citations

Medicine, Cardiology, Pharmacotherapy +17

Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound.

David H. Blankenhorn, Robert H. Selzer, Donald W. Crawford et al. · Circulation · 1993 · 388 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.

Howard N. Hodis, Wendy J. Mack, Stanley P. Azen et al. · Circulation · 1994 · 326 citations · Full text

Medicine, Cardiology, Pharmacology +17

Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.

David H. Blankenhorn, Petar Alaupovic, E Wickham et al. · Circulation · 1990 · 277 citations · Full text

Medicine, Cardiology, Pharmacology +17